Overview
Featured Webinar
The webinar will be uploaded soon. Check back soon!
Featured Article
Expert Reviews

Methodological Reviewer
Andrew E. Giles MD, MPH & Biniam Kidane MD, MSc, FRCSC, University of Manitoba
Clinical Reviewer
Morgan Schellenberg MD, MPH, FRCSC, LAC+USC Medical Center
Clinical Reviewer
Chad G. Ball MD, MSC, FRCSC, FACS, University of Calgary
Questions
Please read the above articles and be prepared to discuss the following:
- What is the clinical question being addressed?
- Was the assignment of patients to treatment randomized and concealed?
- Were all patients who entered the trial properly accounted for and attributed for at is conclusion?
- Were patients, their clinicians and study personnel “blind” to treatment?
- Did novel and standard treatment groups start with the same prognosis?
- Was the effect of the standard treatment preserved?
- Did the investigators analyze patients according to the treatment they received, as well as to the groups to which they were assigned?
- How large and precise was the treatment effect?
- Can the results be applied to my patient care?
- Were all patient-important outcomes considered?
- Are the likely treatment benefits worth the potential harm and costs?
- State the conclusion. Have the authors addressed the clinical question posed?
- Does the evidence support the conclusion?
Brown SG, Ball EL, Perrin K, Asha SE, Braithwaite I, Egerton-Warburton D, et al. Conservative versus Interventional Treatment for Spontaneous Pneumothorax. New England Journal of Medicine. 2020;382(5):405–15.